Sung Ho Park

4.2k citations
58 papers · 2.8k indexed · 1 hit paper · h-index 26

Sung Ho Park

54 papers receiving 2.8k citations

Hit Papers

Immunophenotyping of COVID-19 and influenza highlights th...5302020202620222024100200300400500

Peers

Sung Ho Park
Comparison fields: 5 of 126
  • Immunology 1.2k
  • Infectious Diseases 460
  • Cancer Research 274
  • Biological Psychiatry 42
  • Behavioral Neuroscience 54
Replace Xiang‐Ping Yang with:
Xiang‐Ping Yang China
Derek W. Cain United States
Hans‐Michael Dosch Canada
S Asano Japan
Encarnacion Montecino‐Rodriguez United States
Nicola Heller United States
Laurie S. Davis United States
Cornelia Hardt Germany
Sandra D’Alfonso Italy
Paola Migliorini Italy
Sung Ho Park relative to Xiang‐Ping Yang China Xiang‐Ping Yang's profile →
Citations per field
00.5×3.1×
Xiang‐Ping Yang · 1×
Citations per year

Countries citing papers authored by Sung Ho Park

Since Specialization
Citations

This map shows the geographic impact of Sung Ho Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Ho Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Ho Park more than expected).

Fields of papers citing papers by Sung Ho Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Ho Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Ho Park. The network helps show where Sung Ho Park may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sung Ho Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sung Ho Park Line = papers co-authored together Sung Ho Park links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20245
3 20241
4 20237
5 202332
6 202314
7 202222
8 202247
9 202113
10 20201
11 2019110
12 201986
13 20177
14 2017133
15 2017180
16 2013125
17 201229
18 2010100
19 20106
20 2006148

About Sung Ho Park

Sung Ho Park is a scholar working on Immunology, Cancer Research and Oncology, having authored 58 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immune cells in cancer (9 papers), Immune Cell Function and Interaction (8 papers), Cytokine Signaling Pathways and Interactions (5 papers), T-cell and B-cell Immunology (4 papers), NF-κB Signaling Pathways (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Immunology (1.2k citations), Infectious Diseases (460 citations) and Cancer Research (274 citations). Sung Ho Park has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Lionel B. Ivashkiv, Kyung‐Hyun Park‐Min, Janice Chen, Ευγενία Γιαννοπούλου, Yu Qiao, Keunsoo Kang, Kyuho Kang, Su‐Hyung Park, Jeong Seok Lee and Chae Gyu Park. Their work appears in journals such as Nature Communications, Nature Immunology, Blood, Immunity and Nano Today.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026